The Concannon lab is focused on overcoming resistance in lung cancer, getting to the crux of the genetic component. Research centers around the investigation of driver mutations in lung cancer starting with ALK-positive and ROS1-positive non-small cell lung cancer.
The Schenk lab studies the lung cancer tumor microenvironment, focusing on the immune cells within the tumor and how specific sub-types can contribute to treatment resistance.
Led by Dr. Pine, TORI aims to advance lung cancer research at the University of Colorado, building on a long history of collaborations spanning basic, translational and clinical research.
c92896e8302864d9a5bfff02001ce385.jpg?sfvrsn=600f2b4_0 "Kyle Concannon")
f82996e8302864d9a5bfff02001ce385.jpg?sfvrsn=3701f2b4_0 "Urs Weber")